3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
4
Active not recruiting
3
Terminated
2
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Carcinoma, Non-Small-Cell Lung
72
Lung Neoplasms
9
Adenocarcinoma of Lung
7
Brain Neoplasms
5
Non-squamous Non-small Cell Lung Cancer
4
NSCLC
4
Adenocarcinoma
4
Mesothelioma, Malignant
3
Colorectal Neoplasms
3
Nonsquamous Non-Small Cell Lung Cancer
2
Non-squamous Cell Non-Small Cell Lung Cancer
2
Neoplasms
2
Meningeal Carcinomatosis
2
Lymphoma
2
Glioma
2
Central Nervous System Neoplasms
2
Urinary Bladder Neoplasms
1
Ureteral Neoplasms
1
Untreated Advanced Non-Small Cell Lung Cancer
1
Unresectable Stage III NSCLC
1
Thyroid Neoplasms
1
Thyroid Carcinoma, Anaplastic
1
Thoracic Neoplasms
1
Stomach Neoplasms
1
Stereotactic Radiotherapy; Evoximab (AK112); New Adjuvant Therapy for Non-small Cell Lung Cancer
1
Staging IV NSCLC
1
Squamous Cell Lung Cancer
1
Squamous Cell Carcinoma of Head and Neck
1
Solid Tumor
1
Respiratory Tract Neoplasms
1
Interventions
toripalimab
4
pembrolizumab
4
Gemcitabine
4
tislelizumab
2
durvalumab
2
Nivolumab
2
Cisplatin
2
Carboplatin
2
AZD4547
2
tipifarnib
1
tesetaxel
1
sapanisertib
1
regorafenib
1
pyrotinib
1
nintedanib
1
famitinib
1
disitamab vedotin
1
camrelizumab
1
bintrafusp alfa protein, human
1
atezolizumab
1
anlotinib
1
aldesleukin
1
advexin
1
Vitamin B 12
1
Trastuzumab
1
Taxes
1
Surgical Procedures, Operative
1
Saline Solution
1
Resistance Training
1
Pemetrexed
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Carcinoma, Transitional Cell
×
Pemetrexed
×
Clear all
NCT03193788
2017-06-21
PREMIER
Asan Medical Center
Phase 3
Unknown
74 enrolled